VRDN – viridian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
What Viridian Therapeutics (VRDN)'s 2025 Losses and Thyroid Eye Disease Milestones Mean For Shareholders [Yahoo! Finance]
Viridian Therapeutics (VRDN) had its price target lowered by Royal Bank Of Canada from $45.00 to $42.00. They now have an "outperform" rating on the stock.
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results
Hot Picks: Biotech rebound turns to rare disease catalysts [BNN Bloomberg (Canada)]
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Tousignant Jennifer
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Harmon Seth
Form 4/A Viridian Therapeutics, For: Mar 03 Filed by: Harmon Seth
Form 4/A Viridian Therapeutics, For: Mar 03 Filed by: Tousignant Jennifer
Form 4 Viridian Therapeutics, For: Mar 02 Filed by: Beetham Thomas W.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.